文摘
Alzheimer鈥檚 disease (AD) is an irreversible, multifaceted, and progressive neurodegenerative disorder. Over the past 30 years, the search for anti-AD drugs has been primarily based on the cholinergic deficiency hypothesis and/or the 尾-amyloid (A尾) cascade hypothesis. In this study, we report the identification of 16 new and 38 known 尾-dihydroagarofuran-type sesquiterpenoids from Celastrus flagellaris and Celastrus angulatus. The 尾-dihydroagarofuran-type sesquiterpenoids 58, 59, 61, and 63 significantly attenuated scopolamine-induced prolonged escape latency and increased number of errors compared with the control group. At 10 渭M, 21 of the 62 tested 尾-dihydroagarofuran-type sesquiterpenoids rescued A尾25鈥?5-induced SH-SY5Y cells from viability reduction, which increased the cell viability from 64.6% for the model to more than 74.0%. The majority of the 尾-dihydroagarofuran-type sesquiterpenoids with ester groups exhibited stronger activity than those with free hydroxy groups or without substituents at the same positions. These results identified a new chemical skeleton as drug lead for the investigation of novel therapeutic agents against AD.